Network Office of Research and Innovation

Allentown, Pennsylvania 18103

0 studies enrolling now · 2 studies all time

What they study most

Squamous Cell Non-small Cell Lung Cancer, Unresectable or Metastatic Melanoma

Studies at this site

• Study of Nivolumab (BMS-936558) in Patients With Advanced or Metastatic Squamous Cell Nonsmall-cell Lung Cancer Who Have Received At Least 2 Prior Systemic Regimens — Completed
• A Study to Compare BMS-936558 to the Physician's Choice of Either Dacarbazine or Carboplatin and Paclitaxel in Advanced Melanoma Patients That Have Progressed Following Anti-CTLA-4 Therapy (CheckMate 037) — Completed